← Eichor
Study identifier: NCT05965362 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Prognosis of Patients With Infective Endocarditis and Risk Stratification Value of Biomarkers (ENDEAVOR)

Condition: Infective Endocarditis  ·  Sponsor: First Affiliated Hospital Xi'an Jiaotong University

PhaseN/A
Planned participants2000
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

In this study, by establishing a clinical cohort of infective endocarditis, we observed the natural prognosis and influencing factors in the process of disease development and regression; we used multi-omics technology to understand the prognostic value of its biomarkers, and provided new ideas and evidence for the pathogenesis, clinical diagnosis and treatment of IE.

This description comes directly from the study's public registry record.

Talk to the study team

Guoliang Li  ·  +8613759982523  ·  liguoliang_med@163.com

Yang Yan  ·  +8613259882601  ·  yangyan3@xjtu.edu.cn

Always discuss trial participation with your own doctor first.

Locations (1)

First Affiliated Hospital of Xian Jiantong UniversityXi'an, Shaanxi, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05965362